Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Opaviraline (GW-420867X) is a potent reverse transcriptase inhibitor that inhibits Human immunodeficiency virus 1 and has the potential to treat HIV infection.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 397.00 | |
5 mg | In stock | $ 970.00 | |
10 mg | In stock | $ 1,290.00 | |
25 mg | In stock | $ 1,950.00 | |
50 mg | In stock | $ 2,620.00 | |
100 mg | In stock | $ 3,530.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 867.00 |
Description | Opaviraline (GW-420867X) is a potent reverse transcriptase inhibitor that inhibits Human immunodeficiency virus 1 and has the potential to treat HIV infection. |
In vivo | systemic exposure to GW420867X decreases with increasing dose and displays time-variant pharmacokinetics, which suggests decreased absorption and/or increased clearance of GW420867X. With an approximately 50-hour plasma half-life, GW420867X is well-suited for once-daily dosing due to its relatively prolonged duration of action.[1] |
Synonyms | GW420867X, GW-867, HBY-1293, GW867, GW-420867X |
Molecular Weight | 280.29 |
Formula | C14H17FN2O3 |
CAS No. | 178040-94-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (35.68 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Opaviraline 178040-94-3 Microbiology/Virology Proteases/Proteasome HIV Protease GW420867X GW-867 GW 867 HBY 1293 HBY1293 HBY-1293 GW867 GW-420867X inhibitor inhibit